- Home
- ELOG vs CASI Comparison
ELOG vs CASI Comparison
Compare ELOG & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELOG | CASI |
|---|---|---|
| Founded | 2006 | 1991 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3M | 24.9M |
| IPO Year | 2025 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ELOG | CASI |
|---|---|---|
| Price | $1.15 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.9M | 32.2K |
| Earning Date | 02-10-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.27 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $45,962,309.00 | $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.22 | ★ N/A |
| Revenue Growth | 10.64 | ★ 21.72 |
| 52 Week Low | $0.88 | $0.75 |
| 52 Week High | $3.60 | $3.29 |
Technical Indicators
Market Signals| Indicator | ELOG | CASI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 41.28 |
| Support Level | N/A | $0.83 |
| Resistance Level | N/A | $0.95 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 45.73 |
Price Performance
Historical ComparisonAbout ELOG Eastern International Ltd. Ordinary Shares
Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.